Establishing industry-funded grant programmes for early-stage drug research could help address the dual challenges of declining government funding and optimizing the effectiveness of industry investment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Simpson, P. B. & Reichman, M. Opening the lead generation toolbox. Nature Rev. Drug Discov. 13, 3–4 (2014).
Norman, T. C. et al. Leveraging crowdsourcing to facilitate the discovery of new medicines. Sci. Transl. Med. 3, 88mr1 (2011).
Acknowledgements
The comments and opinions expressed in this article reflect those of the authors and not necessarily their employers (or the companies).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Ladbury, J., Hall, A. & Skidmore, J. The toolbox is open, but who should pay for the job?. Nat Rev Drug Discov 13, 479–480 (2014). https://doi.org/10.1038/nrd4367
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4367
